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The mechanisms which regulate the serum level of T-globulin (or other serum 
proteins) are poorly understood, although a balance between the rate of pro- 
duction (synthesis) and rate of removal (catabolism) must exist for the main- 
tenance of a constant serum level. T-Globulin synthesis has been demonstrated 
in plasmacytes and related cells  of the spleen, lymph node, bone marrow, and 
other tissues following antigenic stimulation (1-3), and the turnover of T-globu- 
lin has been  determined by means of radioisotopically labeled protein.  The 
anatomic and cellular sites of degradation are still unknown, however, and the 
mechanisms regulating the rate of T-globulin catabolism are poorly understood. 
Several observations indicate that the rate of ~,-globulin catabolism may be 
related  to  the  serum  T-globulin  level.  T-Globulin  catabolism  is  generally 
accelerated in patients with increased T-globulin levels due to inflammatory 
diseases (4-9) or plasma cell malignancy (7-11). Similarly in mice with plasma 
cell tumors and large amounts of T myeloma proteins, T-globulin catabolism 
is accelerated (12).  Conversely, prolonged T-globulin survival has been found 
when the serum T-globulin level is low (9,  11,  13,  14).  Two variable factors, 
however,  were  present  in  these  studies;  i.e.,  the  amount  of serum  gamma 
globulin and the number of plasma cells.  Patients with low T-globulin levels 
had  reduced  numbers  of plasma  cells,  and  patients  with large  amounts  of 
~-globulin had increased numbers of plasma cells. Soons and Westenbrink (15), 
on the basis of isotopically labeled protein studies, obtained some evidence that 
plasma cells might be the site of T-globulin destruction. If this is the case, then 
T-globulin catabolism would be increased when the number of plasma cells is 
increased and decreased with plasma cell reduction. Because of the uncertainty 
about the roles of the plasma cells and the serum gamma globulin level, the 
present studies were undertaken to clarify the factors determining the rate of 
T-globulin catabolism. Inbred BALB/c mice were used  (a)  to reduce genetic 
variability to a minimum, (b) because fl,  A-globulins as well as ~,-globulins from 
BALB/c mice were  available in large  quantities,  (c)  because  transplantable 
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plasma  cell  tumors  are  available  in  these  mice,  and  the  relative  amount  of 
plasma  cells  can  be  estimated  in  mice  bearing  subcutaneous  transplants  of 
plasma  cell tumors,  data  which  cannot be obtained in man, and  (d)  because 
parenteral  administration of  large  quantities of  gamma  globulin fractions  is 
feasible in the mouse, whereas quantitative and qualitative factors  make this 
impractical in man.  Tracer  amounts of  radioiodine-labeled normal  mouse "y- 
globulin (NM'y-P 1) were used to measure "y-globulin catabolic rates in normal 
mice,  in hyperimmune hypergammaglobulinemic mice, in  hypergammaglobu- 
linemic mice bearing transplantable plasma  cell tumors,  and in normal mice 
receiving parenterally administered 7-globulins and other serum proteins. 
Methods and Materials 
Mice.--BALB/c  mice were  obtained from the animal production section, National In- 
stitutes of Health. Female mice, 3 months or more of age and weighing 20 to 25 gin, were 
used in these studies. 
Ten mice were immunized by injecting a total of 0.6 mg hemocyanin in six progressively 
enlarging parenteral injections of alum-precipitated hemocyanin to each mouse. A  second 
group  of  ten mice was immunized by intraperitoneal injection of  1 rag hemocyanin and 
Freund's adjuvant and after 6 months given injections of 1 mg of alum-precipitated hemo- 
cyanin 1 and 2 weeks prior to the gamma globulin turnover studies. 
Plasma  Cell Tumors.--Plasma cell tumor lines MPC-1  (16) and MPC-11 were  obtained 
from Dr.  Ruth Merwin, and plasma cell tumor line Adj.PC-5 (17) was obtained from Dr. 
Michael Potter of the National Cancer Institute. The tumors were maintained  by subcutaneous 
implantation of tumor pieces with a trocar. Tumor mice appear to be in good general health 
until the tumor exceeds $ gm. These mice show no morphologic  abnormalities in the kidney. 
The proteins produced by the MPC-11 and Adj.PC-5 tumors are 6.6S "}'-type globulins by 
immunochemical and physicochemical characteristics (17-19), and they migrate as gamma 
globulins on zone electrophoresis.  The MPC-1 myeloma protein is more rapidly migrating and 
has immunochemieal and physieochemical features of fl~A-globulin (18, 19). The quantity 
of myeloma protein and of normal gamma globulin was determined by quantitative paper 
electrophoresis (19) of serum obtained at the end of the turnover study. 
Proteins for Injection.--Mouse T  myeloma protein  was  isolated  by  diethylaminoethyl 
(DEAE) cellulose chromatography of serum obtained from mice bearing the MPC-11 plasma 
cell tumor. Normal human gamma globulin fractions obtained from commercial sources  had 
been prepared by ethanol fractionation (Lederle  Laboratories, Pearl River, New York) and 
by salting out procedures (Courtland Laboratories, Los Angeles) and stored in sterile solution 
until used. The normal human T-globulin preparation obtained by salt fractionation pro- 
cedures induced a more rapid catabolism than the ethanol-prepared human T-globulin or the 
other T-globulin preparations. For example,  (as discussed  below)  a  20 mg/day dose  of the 
ethanol preparation produced a T~'~ (half-time)  of 1.9 days and the salt preparation caused 
a 1.4 day half-time for mouse ")'-globulin. The basis for this difference is uncertain, but a second 
ethanol preparation of normal human "},-globulin  at a dose of 20 rag/day also induced a TI~ 
of 1.9 days for NM~/-1131. Human  "y myeloma protein (type I) was prepared by DEAE cellulose 
chromatography from the serum of a  patient (E.C.) with  multiple myeloma.  Human ~x 
myeloma protein (type II) was prepared by a combination of zone electrophoresis and DEAE 
cellulose chromatography from the serum of a patient (G.F.) with multiple myeloma. Human 
gamma macroglobulin (type  I)  was  obtained from  the  serum  of  a  patient with primary 
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addition of ammonium sulfate to 33  per cent of saturation, reprecipitating twice with am- 
monium sulfate and fractionating the macroglobulin concentrate by DEAE cellulose  chro- 
matography to obtain Tl-macroglobulin essentially free of 6.6S T-globulin.  The procedures 
used to obtain these purified proteins are described in detail elsewhere (20). 
The  protein  preparations were  characterized  by  paper  electrophoresis, immunoelectro- 
phoresis, starch gel electrophoresis, and, in some cases, by ultracentrifugation (18-20).  The 
mouse and human myeloma proteins and macroglobulinemic macroglobulins were essentially 
free of contaminating serum proteins. The normal human gamma globulin preparations were 
composed largely of 6.6S T-globulin but contained up to 10 per cent of the total protein as 
other serum protein components. The albumin preparation was at least 80 per cent albumin 
and  contained no detectable gamma globulin. 
Preparation of S and F Pieces of T-Globulin.--Normal human 6.6S T-globulin preparations 
and mouse T myeloma protein were treated with papain and cysteine as described by Porter 
(21) except that human T-globulin was treated for only 6 hours and the mouse 3' myeloma 
protein for only 1 hour. The S (slow) and F  (fast) pieces were separated by DEAE cellulose 
chromatography (22) and shown by immunoelectrophoresis  and Ouchterlony tests to be free 
of detectable intact 6.6S T-globulin. 
Proteins for  Radioiodine  Labdlng.--Normal  mouse gamma globulin was prepared from 
pooled serum of normal adult BALB/c mice.  Zone electrophoresis was carried out on poly- 
vinyl particle blocks (composed of a  mixture of polyvinyl chloride and polyvinyl chloride- 
polyvinyl acetate copolymer particles  (20, 23). Serial  fractions from the gamma globulin 
region were individually tested for the presence of gamma globulin and other serum proteins 
by the Ouchterlony technique (agar double diffusion employing potent rabbit antisera against 
normal mouse serum and  against normal mouse gamma globulin). Those gamma globulin 
fractions which were  free from  contaminating protein  were  pooled  and  concentrated by 
ultraflltration and tested for purity by starch gel electrophoresis and immunoelectrophoresis 
employing rabbit antinormal mouse serum. The characteristics of the normal mouse gamma 
globulin preparation (NMT) are seen in Fig. 1. Ultracentrifugation revealed that most of the 
protein sedimented (s°2o.w) at about 6.6S. A small amount of a  beta globulin component was 
detected by immunoelectrophoresis, but the bulk of the protein had the features of 6.6S T- 
globulin.  Gamma myeloma proteins from mice bearing the MPC-11 or Adj.PC-5 plasma cell 
tumor were isolated by  DEAE  cellulose  chromatography and  characterized by  starch gel 
electrophoresis, immunoelectrophoresis, and  ultracentrifugation,  and  shown  to  be  6.6  3" 
myeloma proteins. 
Iodination  with I131.--Iodination was performed by the iodine monochloride method of 
McFarlane (24). The amount of iodine introduced corresponded to 0.5 to 1.5 atom per mole- 
cule of protein, taken as 160,000 molecular weight for normal mouse T-globulin and for T 
myeloma protein. Approximately 60 per cent of the added iodine became attached to the 
protein. Mter iodination, free iodine was removed by dialysis against sterile saline, and normal 
mouse serum was added so that the total radioactivity was less than 10/zc per mg of protein. 
The iodinated protein was tested by starch gel electrophoresis, the starch gel being cut into 
5 mm segments which were counted individually in a  gamma scintillation counter, and the 
relative radioactivity was related to the distribution of protein as determined by amido-black 
staining of the opposing half of the starch gel.  As seen in Fig.  1,  the distribution of radio- 
activity corresponded to the T-globulin region of mouse serum. Three normal mouse gamma 
globulin preparations were used in these studies, and each was shown to have the characteristic 
properties of the gamma globulins in normal serum. 
Experimental  Protocols.--Mice  were housed in cages with wire floors which allowed urine 
and fecal droppings to pass through to a tray below. Three or four mice were in each cage and 
were provided with drinking water containing 0.45 per cent NaC1 and 0.01 per cent KI in 848  SERUM  ')t-GLOBULIN  CONCENTRATION 
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order to accelerate renal excretion of free iodine and to reduce uptake of I m  by the thyroid 
gland. Whole body radioactivity was measured daily or more frequently in a gamma ray bulk 
spectrometer (Sharpe Laboratories, LaJolia). Counting was continued long enough to give an 
accuracy of at least 4-5 per cent. All figures were corrected for radioactive decay. 
Mice were injected intravenously with 0.3 pc of I ~1 labeled mouse T-globulin (NMT-I  m) 
in 0.1 ml saline. Each animal was counted within 60 minutes of injection, then at daily in- 
tervals. Data for each animal were calculated separately.  Counting was continued until at 
least one biological half-time survival of the radioiodinated protein was complete. 
Each plasma cell tumor line (~/-tumors MPC-11 and Adj.PC-5,  and ~2A tumor MPC-1) 
was tested in two separate experiments. In the first, three or four mice bearing tumors weigh- 
ing 2  to 5 gm were studied.  Subsequently, tumors were transplanted to a  large number of 
mice. From this group were selected mice with tumor sizes ranging from none or barely de- 
tectable to approximately 3 gm tumor weight. This second group of turnover studies included 
mice with small tumors and serum myeloma protein levels in a  range which also could be 
attained by parenteral protein injection. 
Mice receiving exogenous protein were given NMT-I  m  1 or 2 days prior to starting the 
injections of exogenous protein. Most unlabeled protein injections were given intraperitoneally 
although in the case of human macroglohulins and human ~tA-globulins the initial loading 
dose was given intravenously. An initial loading dose five times greater than the maintenance 
dose was given on the 1st day of protein injection. Subsequently a daily maintenance dose of 
protein was given, and it is this maintenance dose which is recorded in the graphic presenta- 
tion of results. For example, an animal listed as receiving 1 mg of normal human gamma giobu- 
]in per day had been given 5 mg on the 1st day and subsequently received 1 mg of protein 
per day. A maintenance dose was given for 3 successive days, and the following day the ex- 
periment was terminated when the animal was weighed, bled, and the serum saved for pro- 
tein determinations. 
Methods of Co~cu/at/on.--Plasma volumes were calculated from the radioactivity of blood 
samples taken 2 to 3 minutes after injection of known amounts of radioactive protein into a 
tail vein and from a knowledge of the hematocrit. The intravascular T-globulin was calculated 
from the plasma volume and serum concentration data. The fraction of T-giobulin present in 
the intravascular plasma pool in relation to the total body T-globulin content was calculated 
from a  determination of the plasma radioactivity present 24 hours after injection, and com- 
pared with the total body radioactivity at the same time. The catabolism of T-globulin was 
determined by daily measurement of the total body radioactivity. In most experiments the 
radioactivity fell as a straight line function for I week when plotted on semilogarithmic graph 
except in two experiments using T-globulins which had been stored at  5°C  for more than 
1 week. In these cases, an additional 10 to 20 per cent of the radioactivity was removed during 
the first 24 hours, presumably due to removal of altered protein, but within 24 hours of injec- 
tion, the decay curves became straight lines with normal T~  values. The per cent I m  pro- 
tein degraded per day was obtained by dividing the observed half-time into 0.693.  The quan- 
tity of T-globulin in the circulation, the total amount of exchangeable "}'-globulin, and the 
quantity of T-globulin degraded per day were calculated as previously described (12).  The 
quantity of T-globulin degraded per day was determined from the calculation of the total 
body T-globulin and the fraction catabolized per day. 
I~SULTS 
Turno~,er of "y-Glob~in in Normal BALB/c Mice.--Normal 6.6S  'y-globulin 
prepared  from  BALB/c  mice  and  labeled  with  radioiodine  (NM~-1131)  was 
administered intravenously on eight occasions to a  total of twenty-two  normal 850  SERUM "y-GLOBULIN  CONCENTRATION 
BALB/c mice. The whole body radioactivity decay curve for a  typical experi- 
ment is shown in Fig. 2. The observed T~,~ ranged from 3.7 to 4.8 days with an 
average value of 4.1 days. The fractional rate of "y-globulin catabolism per day 
was 0.169. 
The plasma volume was found to be 5 per cent of the body weight, and 49 
per  cent  of the  total  body 7-globulin-113~  was  calculated  to be in  the  intra- 
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FIG. 2. Turnover of normal mouse 7-globulin-I m. Catabolic Decay Curves of radioiodine- 
labeled normal mouse 'y-globulin (NM~'-Im). Median and range of observed data for three 
or more mice in each group are indicated. The hyperimmune mice represent a group of three 
with a mean "/-globulin level of 1.56 gm per cent. The plasma cell tumors MPC-11 and Adj. 
PC-5 produce "y myeloma proteins. The MPC-11 tumors weighed 2.5 to 5.0 gm with a mean 
value of 3.8 gm. The Adj.PC-5 tumors weighed 1.0 to 4.0 (mean 2.5) gm. 
vascular pool. The normal serum "y-globulin level was 0.5 gin per cent and the 
mean  total  body T-globulin was  12.5  mg/25  gm mouse. 
On the basis of this data and the rate of T-globulin catabolism determined 
above,  normal  BALB/c mice  were  calculated  to  degrade  (and,  presumably, 
synthesize)  approximately  2.1  mg "/-globulin per  day per  25  gm mouse; i.e., 
0.084 gm/kg/day. 
Hyperglobulinemia  in  Hyperimmunized  Mice.--Sixteen  mice,  previously 
immunized with hemocyanin, were injected intravenously with NM~/-113L and 
the half-time determined for each mouse. The observed half-times for NM'y-1131 JOHN  L.  ~FAHEY  AND  ALAN  G.  ROBINSON  851 
ranged from 4.3 to 1.9 days in these mice. The mice were then grouped accord- 
ing to their observed T1/~ values, with two to four mice in each of the five groups. 
The mice were sacrificed, the sera pooled for each group, and the serum gamma 
globulin levels determined. 
The serum gamma globulin levels and T1/~ values are compared in Table I. 
The -y-globulin half-time is seen to become progressively shorter as the serum 
gamma globulin levels rise. Accelerated 3"-globulin catabolism is readily evident 
in Fig. 2 where the whole body radioactivity curves for the three hypergamma- 
globulinemic mice included in group D  are plotted. 
These observations indicated  that  the  3,-globulin  catabolic rate might  be 
related to the level of serum 3,-globulin or to the number of plasma cells which 
TABLE I 
Compa~son ~  NMT-I  m  Hdf-Life~th  S~um T-Globulin L~dsin  Immuniz~ Mice 
Group 
A 
B 
C 
D 
E 
No. of 
mice  T~ 
days 
4.0-4.3 
3.5-3.6 
3.3 
2.3-2.7 
1.9-2.2 
Serurtl 
'y-globulin 
gm per cent 
0.50 
0.72 
0.68 
1.56 
2.8O 
lObulin catabo- 
(synthesized) 
rag~g5 gra body 
welgkt]day 
2.1 
3.6 
3.6 
10.4 
24.3 
had increased in response to antigenic stimulation. In normal and hyperimmune 
mice, it was not feasible to measure the number of plasma cells,  but in mice 
bearing transplantable plasma cell tumors the relative quantity of malignant 
plasma  cells can be estimated by tumor measurements. 
Hyperglobulinemia (3" Myeloma Protein) in Mice with Plasma Cell Tumors.- 
Catabolism of NM3"-113! was accelerated in BALB/c mice bearing plasma cell 
tumors producing 3" myeloma proteins. Half-times of 4.4 to 1.5 days were ob- 
served in eighteen mice bearing MPC-11 tumors and in twenty-one mice with 
Adj.PC-5 tumors (Fig. 3). The observed half-times could be correlated roughly 
both with the size of the tumor and with the quantity of 3, myeloma protein 
(Fig. 3); the shortest half-times were found in mice with the largest tumors and 
the greatest amounts of serum 3" myeloma protein. 
The tumor studies, however, did not indicate whether the increased number 
of "y-globulin  producing plasma  cells or the increased serum 3"-globulin  level 
was responsible for the  accelerated  catabolism  of 3"-globulin.  Therefore,  the 
effects of individual proteins on 3"-globulin  metabolism were investigated. 
Effect of Exogenous 3"-Globulin.--Purified mouse 3' myeloma protein MPC-11 
was prepared in large quantity for parenteral administration. This protein was 852  SERUM  'T-GLOBULIN  CONCENTRATION 
injected intravenously or intraperitoneally 1 or 2  days after the intravenous 
injection of NMT-P3~; i.e.,  after equilibration of the labeled h-globulin between 
intravascular  and  extravascular  7-globulin  pools  was  complete.  The  initial 
loading dose was five times larger than  the daily maintenance dose. 
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Fltc. 3,  Relation of NM'y-I  z3t Half-time (T~) to tumor weight and serum myeloma pro- 
tein concentration. After determining the T~,~ values, individual mice were sacrificed, tumors 
weighed,  and the serum  analyzed by paper electrophoresis.  With the "t" myeloma protein 
tumors, MPC-11 and Adj.PC-5, the serum myeloma protein value includes the normal serum 
"y-globulin. In several mice that had received subcuta,ueous implants of the Adj.PC-5 tumor, 
no tumor or serum myeloma protein was evident at the time of sacrifice, thus accounting for 
the normal serum ~'-globulin levels in this experiment.  In the mice with the MPC-1  plasma 
cell tumor, which produces a/~2A myeloma protein, the data for myeloma protein concentra- 
tion does not include the normal serum 5'-globulins. 
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The  effect of injected mouse  7-globulin  (7  myeloma protein MPC-11 )  on 
the catabolism of normal mouse 7-globulin is recorded in Table II. As little as 1 
mg of 7  myeloma protein reduced the half-time of NMT-1181  from 3.8  to 3.3 
days. With increasing amounts of 7  myeloma protein, the half-time of normal 
"y-globulin became progressively shorter, until values of 1.8  to  2.2  days were 
consistently observed. ]OIIN  L.  FAE[EY  AND  ALAN  G.  ROBINSON  853 
TABLE  II 
Effect oflnjectedMouse 3,-Globulin (3,-MP MPC-11) on Catabolism  of  Normal Mouse 3"-Globulin 
Amount of T myeloma protein given i.p.* daily  T~ 
mg 
Control§ 
1 
2 
4 
10 
20 
days 
3.8 
3.3 
2.7 
2.6 
1.8 
1.6 
* Initial  dose of 3' myeloma  protein given intraperitoneaIly  (i.p.)  was five times greater 
than the maintenance dose listed. 
Average values for 3 mice in each group,  except the last, which included 2 mice. 
§ 1 ml isotonic saline injected daily. 
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Fro.  4.  Effect  of %globulin  injections  on  the  half-times  (T~)  of  NM3"-I  1st.  Normal 
mice were injected intravenously with 0.1  nag of NM')'-I  TM.  Two  days later  100 mg of nor- 
mal human ")'-globulin  (0.65 ml)  was injected intraperitoneally and then  20 mg  daily there- 
after. Several mice from the original group that received I~Llabeled protein  were not injected 
with human 3"-globulin  and served as controls. 
Injection  of  human  T-globulins  also  reduced  the  biological  half-time  of 
mouse  ')'-globulin. The effect  of normal  human 3,-globulin on the survival  of 
NM55-I  m is graphically illustrated in Fig. 4. Following intraperitoneal injection 
of  human  55-globulin,  a  marked  acceleration  of  NM55  breakdown  is  evident 854  SERUM ~-GLOBULIN CONCENTRATION 
within  24 hours.  Mouse T-globulin catabolism continues at a  rapid  rate with 
continued human 7-globulin injections.  The effect of human 7-globulin in in- 
creasing  the  catabolism  of mouse  "},-globulin  was  confirmed  in  six  separate 
studies using normal human 7-globulins prepared by ethanol  fractionation or 
by salting-out fractionafion procedures or using 7  myeloma protein  prepared 
by DEAE cellulose chromatography. 
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FIG. 5. ~f[ect of 7-globulin injection on the haif-time (T~) of NMT-1131. Labeled normal 
mouse 7-globulin  (NMT-1131) was injected  intravenously  into normal  BALB/c mice. Two 
days later injections of the proteins listed at the top of each box were beguna~d continued for 
3 or 4 days with maintenance doses of 1, 2, 4, 10, or 20 mg per day (the initial, loading dose 
was five times greater in each instance). The T~ of the NMT-I  m was determined  and  com- 
pared  with the total serum  7-globulin  concentration  (including normal  plus  injected pro- 
tein) as determined by paper electrophoresis. Two studies were made with normal human 7- 
globulin preparations: 
t~, Prepared by salt fractionation;  v0, prepared by ethanol fractionation of human plasma... 
[], mean control value; @, MPC-11 mouse 'y myeloma protein injected; Q, human T mye- 
loma protein injected. 
The effects of three "},-globulins  on the catabolism of NMT-I  m  are illustrated 
in Fig. 5. The T1/~ of NMT-I  m  is compared to the total serum "},-globulin  con- 
centration at the end of each experiment, a value which includes the endogenous 
normal 7-globulin and the exogenously administered protein  (Fig. 6).  In each 
case the T1/~ values fall as the serum 7-globulin level rises,  and the  different 
~/-globulin preparations are seen to produce similar responses in the catabolism 
of NMT-PL 
The 7  myeloma proteins  MPC-11  and Adj.PC-5 were isolated  and labeled 
with I ~3~. Their survival in normal mice was found to be similar to that of nor- 
mal "},-globulins.  In mice with 7-type plasma cell tumors or in mice given exog- JOHN L. I~AHEY AND  ALAN  G. ROBINSON  855 
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FIG. 7.  Comparison of NM~'-I  m  half-time (T~) with total serum T-globulin  level. Ob- 
servation on 85 groups  of mice or individual mice are recorded.  The total T-globulin  con- 
centration includes the normal "y-globulin plus "y myeloma protein or injected "},-globulin  if 
present. The conditions  of the study are indicated by the code: ~, normal BALB/c mice; 
El, immunized;  @,  MPC-11  3'  plasma cell tumor; O,  Adj.Pc-5 T-plasma cell tumor; Z~, 
MPC-1 ~=A plasma cell tumor; []  [!],  injected normal human T-globulin (two experiments);  O, 
injected human "y myeloma protein; X, injected human albumin; @, injected MPC-11  mye- 
loma protein. 
enous ~,-globulin, the catabolism of both myeloma proteins was increased, and 
the  dimensions  of the  changes  in  labeled myeloma protein catabolism were 
similar to  those  seen with labeled normal ~,-globulin. These  observations in- 
dicate that 3' myeloma proteins and normal ~,-globulins are susceptible to the 
same processes controlling the rate  of ~¢-globulin catabolism. JOHN  L.  FAH~Y  AND  ALAN  G.  ROBINSON  857 
Comparison of T-Globulin Survival (T1/~) and Serum T-Globulin Levels.--The 
half-time of NMT-1131 is compared to the serum gamma globulin level (normal 
gamma globulin or normal gamma globulin plus T myeloma protein) in Fig. 
7. The impression that T-globulin catabolism is progressively accelerated with 
increasing T-globulin levels (noted above in individual experiments) is amply 
confirmed in  the  composite  data. 
In the lower range of serum T-globulin levels, i.e., at T-globulin levels below 
0.4 gm per cent, T~l~2 of 5 days or more is seen (Fig. 7). Survival half-time of 
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FIO. 8. Effect of S and F pieces of q~-globulins  on the catabolism of Ira-labeled qz-globulin. 
Alterations  in T-globulin  turnover produced  by injection  of S and F pieces obtained by papain 
treatment of q~-globulin. Mouse "y myeloma  protein Adj.PC-5 labeled with 1181 was injected 
intravenously  into normal BALB/c mice  and 2 days later intraperitoneal  injections  of purified 
S or F pieces were started and repeated at 12 hour intervals. 
normal T-globulin shortened as T-globulin levels rose, reaching T~  values of 
1.8 to 2.0 days at serum T-globulin levels of 2 gm per cent. Further increases in 
serum T-globulin concentration above 2 gm per cent had progressively smaller 
effects on T-globulin half-time. These observations indicate that the fractional 
rate of q-globulin catabolism approaches a maximum; i.e., the greatest rate of 
T-globulin catabolism is approximately 40 per cent of total body T-globulin 
per day in BALB/c mice. 
Molecular Location of Catabolic Configuration.---~-Globulin preparations were 
split into S (slow) and F  (fast) pieces by treatment with papain and cysteine. 
Normal human T-globulin and mouse T myeloma protein Adj.PC-5 were treated 858  SERIY~  'y-GLOBULIN  CONCENTRATION 
in this manner and the S and F pieces separated by DEAE cellulose chromatog- 
raphy.  The effect of injection of these materials  on labeled v-globulin  (1181- 
Adj.PC-5 "yMP) turnover in normal mice is seen graphically in Fig. 8. 
F  (fast)  pieces from mouse V myeloma protein or from normal human 5'- 
globulin accelerated the catabolism of the mouse 5' myeloma protein in the three 
mice given F  piece injections. F  pieces from human T-globulin were given in 
two dose levels, and the larger amount caused a greater increase in T-globulin 
catabolism (Table III). The F  piece represents about one-third of the intact 
v-globulin molecule (21, 25, 26). Therefore, the effect of F piece administration 
TABLE III 
Effect of F and S Pieces (Obtained by Papain Digestion of "I-Globulin) on the Turnover 
of Intact T-Globulin* 
Dose, mg/day~;. 
Equivalent  amount 
'y-globulin  .... 
~1/~, days. 
of  intact 
Control 
m 
4.7 
3'MP 
(mouse) 
2, 1, 1 
3 
3.6 
F pieces 
Normal ~- 
globulin  (man) 
2, 1,1  3, 2,2 
3  6 
3.0  2.4 
S pieces 
"tMP  Normal "F- 
(mouse)  globulin (man) 
4,2,2  4,2,2  6,4,4 
3  3  6 
5.7  6.2  6.3 
* Ira-labeled Adj.PC-5 mouse "y myeloma  protein was injected intravenously into normal 
BALB/c mice 2 days prior to starting intraperitoneal injections of F or S pieces. 
:~ The daily dose of S and F pieces  was divided into two equal amounts which were injected 
intraperitoneally at 12 hour intervals. The total daily dose given on each of 3 days is recorded. 
at a dose of 1 and 2 nag per day may be compared to the effect of 3 and 6 mg 
of intact v-globulin per day (Table III).  On this basis,  the effect of F  piece 
injection appears  to be  approximately equivalent  to  the  effect of intact 3,_ 
globulin  in  accelerating  v-globulin  catabolism. 
S  pieces from human  and mouse v-globulins failed to  increase "},-globulin 
catabolism (Fig. 8). Indeed, "g-globulin  survival appeared to be prolonged by 
injection of S pieces (Table III). The mechanism by which this is achieved is 
not clear. At  the conclusion of the experiment, the mice receiving these in- 
jections were sacrificed and the kidneys examined by hemotoxylin and eosin 
staining  of paraffin blocks and by immunofluorescent examination of  frozen 
sections (27). No renal tubular or glomerular damage was evident in the mice 
receiving either S or F pieces. The renal tubules were free of detectable quanti- 
ties of protein, although appropriate proteins and protein pieces were found 
intravascularly,  both  by  immunofluoreseent  and  immunoelectrophorefic 
studies. Thus there was no morphologic evidence of renal lesions which might 
impair iodide excretion or promote proteinuria. JOHN  L. ]?AIEEY AND  ALAN  O. ROBINSON"  859 
Effects  of ~2A-Globulin,  "/1-Macroglobulin,  and Albumin.--Human  fl~A mye- 
loma protein, "/1-macroglobulin, and albumin were injected in parallel experi- 
ments. As seen in Table IV, these proteins failed to accelerate the catabolism 
of NMT-I  m,  although  appreciable  amounts  of these  proteins were  detected 
by paper  electrophoresis  (Fig.  6)  and  immunoelectrophoresis in  the  sera  of 
injected mice. 
The fl2A myeloma protein tumor (MPC-1) of the mouse, also, failed to ac- 
celerate the  catabolism of NM'/-1131 (Fig.  3).  Half-times of 3.8  to 6.7  days 
(average  =  4.8 days) indicate that q-globulin survival may be prolonged in 
the presence of large quantities of mouse fl~A-globulin. 
TABLE IV 
E.ffe*t of Injeaed Proteins on Catabolism of Normal Mouse T-Globulin 
Protein injected*  T~ 
Control ................................................................ 
Mouse "y myeloma  protein ................................................ 
Human normal 7-globulin  ................................................. 
Human 7 myeloma  protein ................................................. 
Human fl~ myeloma protein .............................................. 
Human 7x-macroglobulin  .................................................. 
Human serum albumin  .................................................... 
days 
4.1 
1.8 
1.8 
2.4 
4.1 
4.4 
4.6 
* 10 mg per day given intraperitoneaUy (except human 71-macroglobulin, which was 
given intravenously) as maintenance dose. Initial dose was 50 mg in each case. 
Effects of Plasma Cells.--The data in Fig. 3 indicate that the large numbers 
of plasma  cells in  the flu-type tumor  (MPC-1)  did not increase "/-globulin 
catabolism. Further, as seen in Fig. 7, T-globulin catabolism is about the same 
in mice with normal plasma cell numbers and elevated T-globulin levels (due 
to  exogenously supplied  T-globulin)  as  in  mice  with  increased plasma  cells 
and increased T-globulins (hyperimmunized mice and mice with T-type plasma 
cell  tumor).  These  observations  indicate  that  the  numbers  of plasma  cells 
probably have little direct effect on "/-globulin catabolism. 
DISCUSSION 
The present observations indicate that  the rate  of "/-globulin synthesis is 
the primary factor determining the serum "/-globulin level. As synthetic rates 
increase, the  serum "/-globulin levels rise and catabolic processes accelerate. 
The mechanisms controlling catabolic rates, however, lag sufficiently that the 
serum 3' globulin level rises to a  new level before catabolic rates match syn- 
thetic rates. 
Synthesis of gamma globulin appears to depend largely on  antigenic  expe- 860  SERIY~  "g-GLOBULIN  CONCENTRATION 
rience. In germ-free animals with very little exposure to antigenic substances, 
the serum gamma globulin levels are low, and may be as low as 10 per cent of 
normal (28, 29). With exposure to infection, serum gamma globulin levels rise 
in  germ-free animals  (28,  29),  presumably due  to increased  synthesis  of "g- 
globulins.  Evidence that immunization causes an increase of "),-globulin  syn- 
thesis in normal mice is seen in Table I. "),-Globulin synthetic rates were found 
to be increased to as much as twenty times normal in the immunized mice. 
Associated with the increase of synthetic rate was  an increase in the serum 
T-globulin level. "g-Globulins from a variety of sources, such as those (a) syn- 
thesized  endogenously in  normal  response  to  antigenic  stimulation,  or  (b) 
synthesized in plasma  cell tumors,  or  (c)  provided from exogenous sources, 
will all raise the total serum "g-globulin level. Synthetic rate appears to be the 
primary factor determining the serum v-globulin level, except in a few patho- 
logic states as noted below. Whether factors other than antigenic  experience 
influence serum "g),-globulin synthesis, however, is uncertain. 
The importance of factors other than synthetic rate in determining serum 
"g-globulin  levels is  illustrated  by a  comparison of mice,  rabbits,  and  man. 
Normal mice synthesize about 85 mg of v-globulin per kg of body weight each 
day as shown in the present study. Rabbits synthesize about 80 mg/kg  (cal- 
culated from data in references 30-32) and man about 36 mg/kg each day (11, 
33). Yet the serum v-globulin levels in these species do not reflect the synthetic 
rates,  for the serum levels in mouse, rabbit,  and man are 0.5, 0.75,  and  1.2 
gm per cent, respectively. The differences between the relative synthetic rate 
and the serum "g-globulin levels, however, are accounted for by the differences 
in catabolic rates. The per cent of the total body "g-globulin  catabolized daily 
is about  17,  12,  and 3 per cent respectively in mouse,  rabbit,  and man.  Al- 
though the mouse has a  high rate of "g-globulin  synthesis,  it has the highest 
relative rate of v-globulin catabolism and,  as a  result, has the lowest serum 
"g-globulin  level of the three species. 
Species differences in "g-globulin  catabolism are related, at least in part, to 
differences in metabolic rate. Observations on "g-globulin catabolism in various 
species (30,  34, 35) indicate that the species with the highest metabolic rates 
had the most rapid rates of v-globulin catabolism. This view is supported by 
the  increase  of  v-globulin  catabolism  during  thyroxin  administration  (30) 
and fever (11). 
Factors, in addition to variations in metabolic rate, also operate to deter- 
mine the rate of "g-globulin catabolism within a species. The serum "g-globulin 
level is one factor as shown in the present studies.  Disease may increase 5'- 
globulin catabolism by a febrile increase of total body metabolism and by anti- 
genic stimulation and inflammatory  processes  which increase the  serum V- 
globulin level. Certain diseases of the gastrointestinal tract  (36)  and kidney 
(37), which cause excessive v-globulin losses  may markedly reduced serum "g- 
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Catabolic rates apparently have a  limit, in the sense that a  maximal frac- 
tional  rate  of 3,-globulin catabolism  is  approached.  As  ~,-globulin levels in- 
crease in  the mouse,  the fraction of the total body T-globulin pool which is 
catabolized daily may increase to 40 per cent per day. This fractional catabolic 
rate is approached when the serum h-globulin level in the mouse reaches 2 
gm per cent. Further increases in serum level have little, if any, effect on in- 
creasing the fractional catabolic rate. 
These findings in the mouse are in accord with the demonstration of a similar 
relationship  between  serum  "r-globulin  concentration  and  catabolic  rate  in 
man (7, 11). The fractional catabolic rate in man, usually about 3 per cent of 
the total body pool per day, may be increased to about 6 to 7 per cent at very 
high "y-globulin  levels (5 gm per 100 ml or more). Higher fractional catabolic 
rates have not been observed, however,  in  afebrile, euthyroid subjects even 
though turnover measurements have been made at "r-globulin levels as high 
as 9 gm per 100 ml. In man and in the mouse, the maximal fractional rate of 
T-globulin catabolism appears to be between two and three times greater than 
the normal fractional catabolic rate. 
In contrast to the apparent limit, or approach to a  limit, in the fractional 
rate of ~,-globnlln  catabolism there is no evidence of a  quantitative limit on 
"r-globulin catabolism. A  mouse with 6 gm per cent serum myeloma protein 
concentration  apparently  catabolized  about  twice  as  much  "y-globulin  per 
day as does a  mouse with 3 gm per cent 3" myeloma protein. 
Under circumstances where the maximal fractional rate of T-globulin catabo- 
lism is closely approached, the fractional rate of T-globulin removal for prac- 
tical purposes is independent of the rate of T-globulin synthesis. This was  re- 
ported  by Humphrey and McFarlane (31) who  compared normal T-globulin 
and antibody catabolism in normal rabbits, in a  rabbit given a  large amount 
of T-globulin by passive transfer,  and  in  a  rabbit  actively hyperimmunized 
to a  high level of  serum  antipneumococcal antibody.  They observed a  con= 
stant  fractional rate of ~'-globulin catabolism (about  12.5  per cent per day) 
but  did  not  detect any  relationship  between  antibody level and  fractional 
rate of catabolism. Although serum T-globulin levels were not reported, these 
observations  need not  be at  variance with those in  the present study if the 
rabbit studies were done at or above the serum T-globulin level which produces 
the maximal fractional rate of T-globulin catabolism in the rabbit.  It is  also 
possible that the rabbit differs from mouse and man in this aspect of "y-globu- 
lin control. 
Albumin metabolism has been extensively investigated, but the relative con- 
tribution  of catabolic processes in  determining serum  albumin  levels is  not 
clear. The findings of Reeve and Roberts (38) in normal rabbits indicated that 
albumin catabolic rateswere not related to serum level or synthetic rate. Studies 
in hyperimmunized rabbits  (32), however, indicated that  the fractional rate 
of albumin catabolism was depressed after serum albumin levels fell. Similarly, 862  SERUM  "/-GLOBULIN CONCENTRATION 
patients  with  analbuminemia  have  low  albumin  catabolic  rates  which  are 
increased toward normal by raising  the serum level (39). Where high serum 
albumin  levels were produced in normal  subjects  by albumin  infusions,  the 
fractional rate of albumin catabolism was increased (40). These latter observa- 
tions on albumin metabolism indicate that the albumin catabolic rate may be 
influenced by serum albumin level in the same manner that T-globulin catabo- 
lism  is  influenced  by the  serum  ")'-globulin  concentration. 
It seems clear, however, that the catabolic processes of some serum proteins 
are not directly influenced by the serum level. In studies of "yl-macroglobulin 
metabolism,  subjects  with  serum  3'l-macroglobulin levels ranging  from 5  to 
5000 per cent of the normal level were found to have similar fractional catabolic 
rates  (41). In studies of transferrin metabolism, Awai and Brown (42)  found 
that  the fractional rate of transferrin catabolism was  often less when serum 
transferrin levels were increased in disease,  and in one subject whose trans- 
ferrin level was raised to twice the normal level via  transferrin infusions, the 
fractional catabolic rate was markedly reduced,--the opposite effect from that 
observed here with "l-globulin. 
The relative discrepancy between albumin and "/-globulin survival in normal 
mice, (half-times of 2.1 and 4.1 days respectively) can be narrowed if the serum 
"/-globulin concentration is raised to a level similar to that of albumin (Table 
V). Gamma globulin levels increased to approximately 3 gm per cent by hyper- 
immunization (Table I, group E) or by other means (Fig. 6), reduce -/-globulin 
half-time to approximately 2.0 days, similar to the 2.1 day half-time observed 
for albumin. As seen in Table V, the absolute rate of degradation is similar for 
both proteins at this serum level. It would be of interest to know if this holds 
true for other species as well. In man, normal "r-globulin survival is  somewhat 
longer, T1/~ =  23 days (11, 33), than albumin, T~,~ =  17 days (43, 44). Extrap- 
olation from the data of Solomon et al. (11) indicates that raising the'/-globu- 
lin level to 4 gm per cent in man (i.e.  equivalent to the normal serum albumin 
level), reduces "/-globulin half-time to about  14 days  (i.e.  somewhat  shorter 
than for albumin). More data on human albumin and "/-globulin turnover at 
several  serum  levels  are  needed,  however,  before  a  definite  comparison  is 
possible. 
Albumin and "/-globulin catabolic processes are similar in being susceptible 
to differences in metabolic rate (34,  35). In other respects, however, processes 
of albumin  and "/-globulin catabolism  appear  to be under separate  control. 
Albumin  catabolism  is  normal  when  "/-globulin  catabolism  is  reduced  (13) 
or increased (12). In the present study, changes in serum albumin level were 
found to have no effect on the rate of "/-globulin catabolism. Also, "/-globulin 
metabolism may be normal in patients with analbuminemia (45). 
The selectivity of the mechanisms determining 6.6S "y-globulin  catabolism 
is demonstrated by their failure to respond to marked increases of the closely JOHN  L.  FAHEY  AND  ALAN  G.  ROBINSON  863 
related flu-globulin and qt~ macroglobulin groups. Processes such as pinocyto- 
sis,  which have been considered as possible mechanisms for removal of serum 
proteins, would not account for the selectivity exhibited by ~,-globulin catabolic 
processes. 
Two processes may contribute  to  the  present  observations  on q-globulin 
metabolism, one mechanism concerned with actual removal and catabolism of 
"y-globulin and a second mechanism regulating the rate of "),-globulin  removal. 
If ")-globulin were catabolized by a  non-selective mechanism which  was  de- 
pendent upon the concentration of ~'-globulin, one would expect a constant rate 
of catabolism. In this study, however, the rate of catabolism was increased as 
TABLE  V 
Comparison of T-Globulin and Albumin Catabolism in BALB/c Mice 
Serum concentration, gm per cent ........ 
Total body content, mg ................. 
T~, days ............................. 
Fractional rate of degradation  (per day) .. 
Absolute turnover rate, rag~25  gm  mouse/ 
day  ................................ 
Albumin 
normal 
3.0 
75 
2.1 
0.333 
25 
T-Globulin 
Raised to 
Normal  3.0 gm per cent 
0.5  3.0 
19.5  75 
4.1  2.0* 
0.16f,  0.347 
2.1  26 
* Obtained from data in Table I  and Fig. 6. 
concentration  increased.  One  biologic mechanism  which  would  explain  this 
observation is  that  more  than  one molecule of ")'-globulin  on  the  catabolic 
receptor might be required before catabolism occurs. The simultaneous pres- 
ence of two molecules is attractive because of its simplicity. Algebraic solu- 
tion of our graphic data does not support a hypothesis that two simultaneous 
molecular hits on the receptor are necessary for catabolism, but the simultane- 
ous presence of two molecules would be plausible if some factor allowed a delay 
between the two hits. Whatever the method of catabolism, there appears to be 
a  homeostatic mechanism sensitive to the serum level and responding to in- 
creased  levels by acceleration of ")'-globulin  catabolism. 
The nature of the sensing mechanism responding to changes in "y-globulin 
levels is unknown. Indeed, it is not certain whether the serum concentration 
or the amount of "y-globulin  in the intravascular pool, in another body pool, 
or in  the  total body "),-globulin  content determines the activity of catabolic 
processes. In the present work, the observed catabolic rates were expressed in 
terms of the serum "y-globulin concentration because this ")-globulin parameter 
could be most accurately measured and a  correlation was readily evident. 864  SERI3"~  T-GLOBULIN CONCENTRATION 
Specificity of control of T-globulin catabolism implies that T-globulin mole- 
cules have a specific configuration which is recognized by the sensing mechanism 
of the process regulating "r-globulin catabolic rate. The finding that injection 
of F  pieces from T-globulin accelerates T-globulin catabolism indicates that 
the catabolic control site is on the F piece. This is supported by evidence that 
/~2A-globulins and Tl-macroglobulins do not accelerate T-globulin catabolism. 
Current hypotheses (46-49)  view the 6.6S T-globulin molecules as being com- 
posed of several types of polypepfide chains. One type of polypeptide chain is 
present only in 6.6S  ")'-globulin molecules and is not present in fl2A-globulins 
or "ym-macroglobulins. At least a part of the polypeptide chain unique to 6.6S 
T-globulin (i.e.  not on f~A-globulin  or T~-globulin), is represented in the  F 
piece obtained after papain digestion. The finding of the catabolic control site 
on the F piece is in accord with evidence that other specific properties of 6.6S 
"y-globulin are on the F pieces. 
The control of T-globulin catabolism probably is similar in many species. 
The  turnover  rate  of heterologous 5,-globulin  is  largely determined by  the 
metabolic rate of the recipient (12, 30, 50).  Also, large amounts of exogenous 
T-globulin of heterologous and isologous origin similarly accelerate the catabo- 
lism of isologous normal T-globulin. 
The  observations  reviewed above indicate  that  several  factors determine 
the  metabolic fate of T-globulin. These include metabolic rate  of the host; 
specific  features of the protein molecule; the serum "y-globulin level and, in- 
directly, the T-globulin synthetic rate. Further studies are needed to elucidate 
the mechanisms controlling T-globulin catabolism,  the anatomic location of 
the homeostatic and catabolic sites, and the means of communication between 
these sites. 
S~Y 
Both  synthetic  and  catabolic  processes  determine  the  serum  T-globulin 
level. The rate of T-globulin synthesis appears to be the primary factor deter- 
mining the amount of serum T-globulin. Increase of T-globulin synthesis (as 
may  occur  following immunization or  development  of  plasma  cell  tumor) 
elevates the  serum T-globulin level. This,  in turn,  accelerates  the fractional 
rate  of T-globulin catabolism. The change in catabolic rate  reduces  the di- 
mensions of the serum change from that which would occur ff synthesis alone 
determined the serum T-globulin level. The present studies indicate the exist- 
ence of a  homeostatic mechanism controlling the rate of T-globulin catabolism. 
The mechanisms of T-globulin catabolism are specific and selective. Marked 
serum  increase  of other  immunoglobulin components  (~2A-globulins and T1- 
macroglobulins) do not accelerate T-globulin catabolism. Similarly, serum al- 
bumin increases do not influence T-globulin catabolism. 
The  site  determining T-globulin catabolism is  restricted  to  a  part  of the JOHN  L.  FAHEY  AND  ALAN  G.  ROBINSON  865 
"y-globulin molecule; i.e., on the F piece obtained by papain digestion and, by 
inference, on the H  chains obtained by reduction and alkylation of 3,-globulin 
molecules. 
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